These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 24131245)
1. Treatment of subretinal fluid associated with dome-shaped macula. Chinskey ND; Johnson MW Ophthalmic Surg Lasers Imaging Retina; 2013 Nov; 44(6):593-5. PubMed ID: 24131245 [TBL] [Abstract][Full Text] [Related]
2. TRANSCLERAL DRAINAGE OF SUBRETINAL FLUID, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR, AND WIDE-FIELD IMAGING-GUIDED LASER IN COATS EXUDATIVE RETINAL DETACHMENT. Stanga PE; Jaberansari H; Bindra MS; Gil-Martinez M; Biswas S Retina; 2016 Jan; 36(1):156-62. PubMed ID: 26355946 [TBL] [Abstract][Full Text] [Related]
3. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration]. Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687 [TBL] [Abstract][Full Text] [Related]
4. Coats' disease: treatment with intravitreal bevacizumab and laser photocoagulation. Stergiou PK; Symeonidis C; Dimitrakos SA Acta Ophthalmol; 2009 Sep; 87(6):687-8. PubMed ID: 18976310 [No Abstract] [Full Text] [Related]
5. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction. Ramasubramanian A; Shields CL Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215 [TBL] [Abstract][Full Text] [Related]
6. Bilateral intravitreal bevacizumab injection for exudative age-related macular degeneration: effect of baseline visual acuity. Jonas JB; Tao Y; Rensch F J Ocul Pharmacol Ther; 2011 Aug; 27(4):401-5. PubMed ID: 21810019 [TBL] [Abstract][Full Text] [Related]
7. [Pathophysiology of macular diseases--morphology and function]. Iida T Nippon Ganka Gakkai Zasshi; 2011 Mar; 115(3):238-74; discussion 275. PubMed ID: 21476310 [TBL] [Abstract][Full Text] [Related]
8. Resolution of Unilateral Dome-Shaped Macula With Serous Detachment After Treatment of Topical Carbonic Anhydrase Inhibitors. Chen NN; Chen CL; Lai CH Ophthalmic Surg Lasers Imaging Retina; 2019 Aug; 50(8):e218-e221. PubMed ID: 31415708 [TBL] [Abstract][Full Text] [Related]
9. Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab. Bakall B; Folk JC; Boldt HC; Sohn EH; Stone EM; Russell SR; Mahajan VB Am J Ophthalmol; 2013 Jul; 156(1):15-22.e1. PubMed ID: 23706500 [TBL] [Abstract][Full Text] [Related]